Initial Public Offering

Tariff Impact Forces 58 Companies to Delay IPO Plans – Check How It Could Affect Investors!

The 2025 IPO landscape is reeling as 58 companies globally delay their public listing plans, thanks to volatile markets triggered by U.S. trade tariffs. Indian firms like Avanse Financial and Anthem Biosciences are among the affected. This slowdown impacts retail investors, VCs, and startups alike. Learn what’s causing the delay, how to react smartly, and when IPO activity might recover—plus practical investment tips to navigate the turmoil.